These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26656888)

  • 1. Inhibiting bacterial toxins by channel blockage.
    Bezrukov SM; Nestorovich EM
    Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26656888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructing toxin pathways by targeted pore blockage.
    Nestorovich EM; Bezrukov SM
    Chem Rev; 2012 Dec; 112(12):6388-430. PubMed ID: 23057504
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.
    Johnson SL; Chen LH; Barile E; Emdadi A; Sabet M; Yuan H; Wei J; Guiney D; Pellecchia M
    Bioorg Med Chem; 2009 May; 17(9):3352-68. PubMed ID: 19359184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivalent Inhibitors of Channel-Forming Bacterial Toxins.
    Yamini G; Nestorovich EM
    Curr Top Microbiol Immunol; 2017; 406():199-227. PubMed ID: 27469304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function analysis of VapB4 antitoxin identifies critical features of a minimal VapC4 toxin-binding module.
    Jin G; Pavelka MS; Butler JS
    J Bacteriol; 2015 Apr; 197(7):1197-207. PubMed ID: 25622615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing inhibitors of anthrax toxin.
    Nestorovich EM; Bezrukov SM
    Expert Opin Drug Discov; 2014 Mar; 9(3):299-318. PubMed ID: 24447197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insilico studies on anthrax lethal factor inhibitors: pharmacophore modeling and virtual screening approaches towards designing of novel inhibitors for a killer.
    Roy J; Kumar UC; Machiraju PK; Muttineni RK; Kumar B V S S; Gundla R; Dayam R; Sarma JA
    J Mol Graph Model; 2010 Sep; 29(2):256-65. PubMed ID: 20727800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of anthrax lethal factor based upon N-oleoyldopamine.
    Gaddis BD; Rubert Pérez CM; Chmielewski J
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2467-70. PubMed ID: 18314330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening.
    Chiu TL; Solberg J; Patil S; Geders TW; Zhang X; Rangarajan S; Francis R; Finzel BC; Walters MA; Hook DJ; Amin EA
    J Chem Inf Model; 2009 Dec; 49(12):2726-34. PubMed ID: 19928768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitoxins: novel strategies to target agents of bioterrorism.
    Rainey GJ; Young JA
    Nat Rev Microbiol; 2004 Sep; 2(9):721-6. PubMed ID: 15372082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of peptides that trigger Streptococcus pneumoniae cell death.
    Kang SM; Jin C; Kim DH; Park SJ; Han SW; Lee BJ
    FEBS J; 2021 Mar; 288(5):1546-1564. PubMed ID: 32770723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Introduction to the Toxins Special Issue on "Novel Pharmacological Inhibitors for Bacterial Protein Toxins".
    Barth H
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28492500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of a heptavalent anthrax toxin inhibitor.
    Joshi A; Kate S; Poon V; Mondal D; Boggara MB; Saraph A; Martin JT; McAlpine R; Day R; Garcia AE; Mogridge J; Kane RS
    Biomacromolecules; 2011 Mar; 12(3):791-6. PubMed ID: 21302959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Dendrimer Terminal Group Chemistry on Blockage of the Anthrax Toxin Channel: A Single Molecule Study.
    Yamini G; Kalu N; Nestorovich EM
    Toxins (Basel); 2016 Nov; 8(11):. PubMed ID: 27854272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AB(5) toxins: structures and inhibitor design.
    Fan E; Merritt EA; Verlinde CL; Hol WG
    Curr Opin Struct Biol; 2000 Dec; 10(6):680-6. PubMed ID: 11114505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the hemolytic activity caused by Staphylococcus aureus alpha-hemolysin through isatin-Schiff copper(II) complexes.
    Melo MC; Teixeira LR; Pol-Fachin L; Rodrigues CG
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv207. PubMed ID: 26519261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Functional Study of the
    Kang SM; Jin C; Kim DH; Lee Y; Lee BJ
    J Med Chem; 2020 Nov; 63(22):13669-13679. PubMed ID: 33146528
    [No Abstract]   [Full Text] [Related]  

  • 19. Voltage gating is a fundamental feature of porin and toxin beta-barrel membrane channels.
    Bainbridge G; Gokce I; Lakey JH
    FEBS Lett; 1998 Jul; 431(3):305-8. PubMed ID: 9714531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering nanoparticle antitoxins utilizing aromatic interactions.
    Weisman A; Chen YA; Hoshino Y; Zhang H; Shea K
    Biomacromolecules; 2014 Sep; 15(9):3290-5. PubMed ID: 25093686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.